With Three Guidelines on H pylori, What Should Clinicians Do? With Three Guidelines on H pylori, What Should Clinicians Do?
Helicobacter pylori has been the subject of countless recommendations for best practice management. A brief review of some changes reflected in three guidelines is provided to help clinicians.Medscape Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 29, 2018 Category: Consumer Health News Tags: Gastroenterology Viewpoint Source Type: news
Medical News Today: What are the best natural H. pylori treatments?
The bacteria H. pylori can cause a range of gastrointestinal issues, including gastritis. Infection may even lead to gastric cancer. Fortunately, there are many natural ways to help treat it, including honey, aloe vera, broccoli sprouts, and lemongrass oil. Learn about eight natural treatments for H. pylori here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 31, 2018 Category: Consumer Health News Tags: GastroIntestinal / Gastroenterology Source Type: news
Global Resistance to Anti-H. Pylori Drugs Rising (CME/CE)
(MedPage Today) -- Regionally targeted eradication regimens are needed, researchers say (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - July 13, 2018 Category: American Health Source Type: news
Houston Consensus Shrinks Gaps in H. Pylori Management (CME/CE)
(MedPage Today) -- 29 new recommendations to help eliminate active disease especially in at-risk subgroups (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 27, 2018 Category: Primary Care Source Type: news
Antibiotic Resistance and Efficacy of Therapy for H. Pylori Antibiotic Resistance and Efficacy of Therapy for H. Pylori
How prevalent is primary resistance to the three antimicrobial agents most commonly used in H. pylori eradication regimens? Is sequential therapy an effective option to improve outcomes?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 26, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Helicobacter Pylori: A Better Test, Low Cure Rates, High Resistance - 3 Studies from DDW
Highlights of H. pylori-focused research at Digestive Disease Week: a noninvasive assessment tool, need for eradication testing, and patterns of treatment resistance. (Source: ConsultantLive)
Source: ConsultantLive - June 10, 2018 Category: Internal Medicine Authors: Veronica Hackethal, MD Tags: Conferences/Digestive Disease Week Source Type: news
Study: Disease-causing stomach bug attacks energy generation in host cells
(University of Illinois at Urbana-Champaign) Researchers report in a new study that the bacterium Helicobacter pylori -- a major contributor to gastritis, ulcers and stomach cancer -- resists the body's immune defenses by shutting down energy production within the cells of the stomach lining that serve as a barrier to infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 30, 2018 Category: Infectious Diseases Source Type: news
Bacterial manipulation of host cell metabolism
A Helicobacter pylori exotoxin manipulates host cell metabolism by inducing amino acid starvation and inhibiting mTORC1 signaling. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - May 29, 2018 Category: Science Authors: VanHook, A. M. Tags: STKE Editors ' Choice Source Type: news
Durham pharma eyes potential approval of drug in roughly $5B market
RedHill Biopharma (Nasdaq: RDHL) – which continued to grow its U.S. commercial operations based in Raleigh over the course of 2017 – has its sights set on potential approval of a drug in a market worth roughly $5 billion.
RedHill expects to compete enrollment of close to 450 patients in an ongoing Phase III study for its dru g candidate TALICIA for the treatment of H. pylori infection – which can cause chronic gastritis, ulcers and gastric cancer – in the third quarter of this year.
As… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 7, 2018 Category: Biotechnology Authors: Jennifer Henderson Source Type: news
H. Pylori Linked to Atherosclerosis in Healthy People (CME/CE)
(MedPage Today) -- Infected individuals with no history of coronary heart disease had significant subclinical atherosclerosis (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 31, 2018 Category: Cardiology Source Type: news
Consensus Details H pylori Testing, Treatment for US Patients Consensus Details H pylori Testing, Treatment for US Patients
Consensus document outlines who should be tested and treated for H pylori infection to reduce adverse health consequences of long-term infection.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 29, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Orthotics and Heel Pain; Bacteria and Cancer: It's PodMed Double T! (with audio)
(MedPage Today) -- This week ' s topics include infants with bronchiolitis, orthotics for heel pain, behavioral therapy in dementia, and H. pylori infection in early gastric cancer (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - March 24, 2018 Category: Psychiatry Source Type: news
Treating H. Pylori Cuts Metachronous Cancer Rate
(MedPage Today) -- 50% reduction in endoscopically resected gastric cancer (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 22, 2018 Category: Gastroenterology Source Type: news
H pylori Eradication Benefits Patients With Early Gastric Cancer H pylori Eradication Benefits Patients With Early Gastric Cancer
Patients with early gastric cancer treated for Helicobacter pylori had a lower incidence of metachronous gastric cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 21, 2018 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
